Lithium Treatment: Focus on Long-Term Prophylaxis

Bipolar Psychopharmacotherapy: Caring for the Patient: Second Edition

Volumn , Issue , 2011, Pages 9-23

  Grof, Paul ^a   Schou, Mogens ^b  

^a Mood Disorders Center of Ottawa   (Canada)

^b NONE

Author keywords

"Naturalistic" Trials; Breastfeeding during lithium treatment; Cade's Pioneering Study; Double blind discontinuation trial; Lithium Treatment Focus on Long Term Prophylaxis; Non Blind Mirror Trial

Indexed keywords

EID: 84871575105     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470975114.ch2     Document Type: Chapter

References (87)

1. Akiskal, H.S. (1999) Affective disorders, in Merck Manual of Diagnosis and Therapy, 14th edn (ed. R. Berkow), Merck, Sharp and Dohme Research Laboratories, New Jersey, pp. 1525-1544..
2. Akiskal, H.S. (2002) The bipolar spectrum - the shaping of a new paradigm in psychiatry. Curr. Psychiatry Rep., 4 (1), 1-3.
3. Akiskal, H.S., Bourgeois, M.L., Angst, J. et al. (2000) Reevaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J. Affect. Disord., 59 (Suppl. 1), 5s-30s.
4. Akiskal, H.S., Hantouche, E.G., Allilaire, J.F. et al. (2003) Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II). J. Affect. Disord., 73, 65-74.
5. Angst, J., Gamma, A., Benazzi, F. et al. (2003) Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J. Affect. Disord., 23, 133-146.
6. Angst, J. and Weis, P. (1969) Zum Verlauf depressiver Psychosen. In W. Schulte and W. Mende (Eds.), Melancholie in Forschung, Klinik und Behandlung, pp. 2-9. Stuttgart: Georg Thieme.
7. Angst, J., Weis, P., Grof, P. et al. (1970) Lithium prophylaxis in recurrent affective disorders. Br. J. Psychiatry, 116, 604-614.
8. Baastrup, P.C. (1964) The use of lithium in manic-depressive psychosis. Compr. Psychiatry, 5, 396-408.
9. Baastrup, P.C., Poulsen, J.C., Schou, M. et al. (1970) Prophylactic lithium: double-blind discontinuation in manic-depressive disorders. Lancet, II, 326-330.
10. Baastrup, P.C. and Schou, M. (1967) Lithium as a prophylactic agent: its effect against recurrent depressions and manic-depressive psychosis. Arch. Gen. Psychiatry, 16, 162-172.
11. Baastrup, P.C. and Schou, M. (1968) Prophylactic lithium. Lancet, I, 1419-1422.
12. Baldessarini, R.J., Tondo, L., and Hennen, J. (2001) Treating the suicidal patient with bipolar disorder. Reducing suicide risk with lithium. Ann. N. Y. Acad. Sci., 932, 24-38.
13. Bendz, H., Sj̈odin, I., and Aurell, M. (1996) Renal function on and off lithium in patients treated with lithium for 15 years or more: a controlled, prospective lithium withdrawal study. Nephrol. Dial. Transplant., 11, 457-460.
14. Bergḧofer, A., Kossman, A.B., and M̈uller-Oerlinghausen, B. (1996) Course of illness and pattern of recurrences in patients with affective disorders during long-term lithium prophylaxis: a retrospective analysis over 15 years. Acta Psychiatr. Scand., 93, 349-354.
15. Birch, N.J., Grof, P., Hullin, R.P. et al. (1993) Lithium prophylaxis: proposed guidelines for good clinical practice. Lithium, 4, 225-230.
16. Blackwell, B. and Shepherd, M. (1968) Prophylactic lithium: another therapeutic myth? An examination of the evidence to date. Lancet, I, 968-971.
17. Cade, J.F.J. (1949) Lithium salts in the treatment of psychotic excitement. Med. J. Aust., 36, 349-352.
18. Coppen, A., Noguera, R., Bailey, J. et al. (1971) Prophylactic lithium in affective disorders: controlled trial. Lancet, II, 275-279.
19. Coppen, A., Standish-Barry, H., Bailey, J. et al. (1991) Does lithium reduce the mortality of recurrent mood disorders? J. Affect. Disord., 23, 1-7.
20. Chun, B.J.D.H. and Dunner, L.D. (2004) A review of antidepressant-induced hypomania in major depression: suggestions for DSM-V. Bipolar Disord., 6, 32-42.
21. Cundall, R.L., Brooks, P.W., and Murray, L.G. (1972) A controlled evaluation of lithium prophylaxis in affective disorders. Psychol. Med., 2, 308-311.
22. Dickson, W.E. and Kendell, R.E. (1986) Does maintenance lithium therapy prevent recurrences of mania under ordinary clinical conditions? Psychol. Med, 16, 521-530.
23. Fyr̈o, B. and Petterson, U. (1977) A double blind study of the prophylactic effect of lithium in manic-depressive illness. Acta Psychiatr. Scand., 269, 17-22.
24. Gelenberg, A.J., Kane, J.M., Keller, M.B. et al. (1989) Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N. Engl. J. Med., 321, 1489-1493.
25. Gershon, S. and Soares, J.C. (1997) Current therapeutic profile of lithium. Arch. Gen. Psychiatry, 54, 16-20.
26. Gitlin, M.J. (1993) Lithium-induced renal insufficiency. J. Clin. Psychopharmacol., 13, 276-279.
27. Gitlin, M.J. and Altshuler, L.L. (1997) Unanswered questions, unknown future for one of our oldest medications. Arch. Gen. Psychiatry, 54, 21-23.
28. Goodwin, G.M. (1995) Lithum revisited. A reply. Br. J. Psychiatry, 167, 573-574.
29. Goodwin, F.K., Fireman, B., Simon, G.E. et al. (2003) Suicide risk in bipolar disorder during treatment with lithium and divalproex. J. Am. Med. Assoc., 290, 1467-1473.
30. Greil, W. and Kleindienst, N. (1999) Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified. Int. Clin. Psychopharmacol., 14, 283-285.
31. Greil, W., Kleindienst, N., Erazo, N., and M̈uller-Oerlinghausen, B. (1998) Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J. Clin. Psychopharmacol., 18, 455-460.
32. Greil, W., Ludwig-Mayerhofer, W., Erazo, N. et al. (1997) Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study. Eur. Arch. Psychiatry Clin. Neurosci., 247, 42-50.
33. Grof, P. (1987) Admission rates and lithium therapy. Br. J. Psychiatry, 150, 264-265.
34. Grof, P. (1998) Has the effectiveness of lithium changed? Impact of the variety of lithium's effects. Neuropsychopharmacology, 19, 183-188.
35. Grof, P. (2003) Selecting effective long-term treatment for bipolar patients: monotherapy and combination therapy. J. Clin. Psychiatry, 64 (Suppl. 5), 53-61.
36. Grof, P., MacCrimmon, D., Smith, E.K.M. et al. (1980) Long-term lithium treatment and the kidney. Can. J. Psychiatry, 25, 535-544.
37. Grof, P., Schou, M., Angst, J. et al. (1970a) Methodological problems of prophylactic trials in recurrent affective disorders. Br. J. Psychiatry, 116, 599-603.
38. Grof, P., Cakuls, P., and Dostal, T. (1970b) Lithium drop-outs: a follow-up study of patients who discontinued prophylactic treatment. Int. Pharmacopsychiatry, 5, 162-169.
39. Guscott, R. and Taylor, L. (1994) Lithium prophylaxis in recurrent affective illness: efficacy, effectiveness and efficiency. Br. J. Psychiatry, 164, 741-764.
40. Hanus, K. and Zapletalek, M. (1984) Suicidal activity of patients with affective disorders during the preventive use of lithium. Cesk. Psychiatr., 80, 97-100.
41. Hartigan, G.P. (1963) The use of lithium salts in affective disorders. Br. J. Psychiatry, 109, 810-814.
42. Healy, D. (ed.) (1997) Lithium. Interview with Mogens Schou, The Psychopharmacologists II, Chapman & Hall, London, pp. 259-284.
43. Hullin, R.P., McDonald, R., and Allsopp, M.N.E. (1972) Prophylactic lithium in recurrent affective disorders. Lancet, 1, 1044-1046.
44. Jacobson, S.J., Jones, K., Johnson, K. et al. (1992) Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet, 339, 530-533.
45. Jamison, K.R. (1986) Suicide and bipolar disorders. Ann. N. Y. Acad. Sci., 487, 301-315.
46. Johnson, F.N. (1984) The History of Lithium Treatment, Mcmillan, London.
47. Judd, L.L. and Akiskal, H.S. (2003) The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J. Affect. Disord., 73, 123-131.
48. Kallner, G., Lindelius, R., Petterson, U. et al. (2000) Mortality in 497 patients with affective disorders attendending a lithium clinic or after having left it. Pharmacopsychiatry, 33, 8-13.
49. Lange, C. (1886) Bidrag til urinsyrediatesens klinik. Hospitalstidende, 5, 1-15, 21-38, 45-63, 69-83.
50. Melia, P.I. (1970) Prophylactic lithium: a double-blind trial in recurrent affective illness. Br. J. Psychiatry, 116, 621-624.
51. Mendlewicz, J. (1984) Lithium discontinuation in bipolar Illness: a double-blind prospective controlled study, in Current Trends in Lithium and Rubidium Therapy (ed. G.U. Corsini), MTP Press, Stuttgart, pp. 125-141.
52. Moncrieff, J. (1995) Lithium revisited: a re-examination of the placebo-controlled trials of lithium prophylaxis in manic-depressive disorder. Br. J. Psychiatry, 167, 569-574.
53. M̈uller-Oerlinghausen, B., Ahrens, B., Grof, E. et al. (1992) The effect of long-term lithium treatment on the mortality of patients with manic-depressive or schizo-affective illness. Acta Psychiatr. Scand., 86, 218-222.
54. Passmore, M.J., Garnham, J., Duffy, A. et al. (2003) Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine. Bipolar Disord., 5, 110-114.
55. Placidi, G.F., Lenzi, A., Lazzerini, F. et al. (1986) The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind, 3-year trial in 83 patients. J. Clin. Psychiatry, 47, 490-494.
56. Povlsen, U.J., Hetmar, O., Ladefoged, J., and Bolwig, T.B. (1992) Kidney functioning during lithium treatment: a prospective study of patients treated with lithium for up to ten years. Acta Psychiatr. Scand., 85, 56-60.
57. Prien, R.F., Caffey, E.M., and Klett, C.J. (1973) Prophylactic efficacy of lithium carbonate in manic-depressive illness. Arch. Gen. Psychiatry, 28, 337-341.
58. Reifman, A. and Wyatt, R.J. (1980) Lithium: a brake in the rising cost of mental illness. Arch. Gen. Psychiatry, 37, 355-388.
59. Rifkin, A.F., Quitkin, F., and Howard, A. (1975) A study of abrupt lithium withdrawal. Psychopharmacology, 44, 157-158.
60. Sashidharan, S.P. and McGuire, R.J. (1983) Recurrence of affective illness after withdrawal of long-term lithium treatment. Acta Psychiatr. Scand., 68, 126-133.
61. Schioldann, J. (2001) In Commemoration of the Century of the Death of Carl Lange. The Lange Theory of 'Periodical Depressions'. A Landmark in the History of Lithium Therapy, Adelaide Academic Press.
62. Schou, M. (1956) Lithiumterapi ved mani: praktiske retningslinier. Nord. Med., 55, 790-794.
63. Schou, M. (1969) The 'Scandinavian register of lithium babies', in Lithium in Psychiatry, Acta Psychitr. Scand. Suppl., Vol. 207 (eds N. Diding, J.O. Ottosson, and M. Schou), p. 97.
64. Schou, M. (1986) Admission rates and lithium therapy. Br. J. Psychiatry, 149, 798-799.
65. Schou, M. (1988) Effects of long-term lithium treatment on kidney function: an overview. J. Psychiatr. Res., 22, 287-296.
66. Schou, M. (1990) Lithium treatment during pregnancy, delivery, and lactation. An update. J. Clin. Psychiatry, 51, 410-413.
67. Schou, M. (1992) Phases in the development of lithium treatment in psychiatry, in The Neurosciences: Paths of Discovery, vol. 2 (eds F. Samson and G. Adelman), Birkḧauser, Boston, pp. 147-166.
68. Schou, M. (1993a) Lithium prophylaxis: about 'naturalistic' or 'clinical practice' studies. Lithium, 4, 77-81.
69. Schou, M. (1993b) Lithium Treatment of Manic-Depressive Illness: A Practical Guide, 5th edn, Karger, Freiburg, London, New York.
70. Schou, M. (1997) The combat of non-compliance during prophylactic lithium treatment. Acta Psychiatr. Scand., 95, 361-363.
71. Schou, M. (1998a) Has the time come to abandon prophylactic lithium treatment? A review for clinicians. Pharmacopsychiatry, 31, 210-215.
72. Schou, M. (1998b) Treating recurrent affective disorders during and after pregnancy: what can be taken safely? Drug Saf., 18, 143-152.
73. Schou, M. (1998c) The effect of prophylactic lithium treatment on mortality and suicidal behavior: a review for clinicians. J. Affect. Disord., 50, 253-259.
74. Schou, M. (2000) Suicidal behavior and prophylactic lithium treatment of major mood disorders: a review for clinicians. Suicide Life Threat. Behav., 30, 289-293.
75. Schou, M. (2001) Lithium treatment at 52. J. Affect. Disord., 67, 21-23.
76. Schou, M. and Kampf, D. (2006) Lithium and the kidneys, in Lithium in Neuropsychiatry (eds M. Bauer, P. Grof, and B., M̈uller-Oerlinghausen), Informa, London, pp. 251-259.
77. Schou, M., Juel-Nielsen, N., Str̈omgren, E., and Voldby, H. (1954) The treatment of manic psychoses by the administration of lithium salts. J. Neurol. Neurosurg. Psychiatry, 17, 250-260.
78. Schou, M., Thomsen, K., and Baastrup, P.C. (1970) Studies on the course of recurrent endogenous affective disorders. Int. Pharmacopsychiatry, 5, 100-106.
79. Schou, M. and Vestergaard, P. (1988) Prospective studies on a lithium cohort. 2. Renal function. Water and electrolyte metabolism. Acta Psychiatr. Scand., 78, 427-433.
80. Stallone, F., Shelley, E., Mendlewicz, J., and Fieve, R.R. (1973) The use of lithium in affective disorders, III. A double-blind study of prophylaxis in bipolar illness. Am. J. Psychiatry, 130, 1006-1010.
81. Suppes, T., Baldessarini, R.J., Faedda, G.I. et al. (1993) Discontinuation of maintenance treatment of bipolar disorder: risks and implications. Harv. Rev. Psychiatry, 1, 131-144.
82. Thomsen, K. and Schou, M. (1999) Avoidance of lithium intoxications: advice based on knowledge about the renal lithium clearance under various circumstances. Pharmacopsychiatry, 32, 83-86.
83. Tondo, L., Jamison, K.R., and Baldessarini, R.J. (1997) Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann. N. Y. Acad. Sci., 836, 339-351.
84. Vestergaard, P., Poulstrup, I., and Schou, M. (1988) Prospective studies on a lithium cohort. 3. Tremor, weight gain, diarrhea, psychological complaints. Acta Psychiatr. Scand., 78, 343-441.
85. Vestergaard, P. and Schou, M. (1988) Prospective studies on a lithium cohort. 1. General features. Acta Psychiatr. Scand., 78, 434-441.
86. Wyatt, R.J. and Henter, I. (1995) An economic evaluation of manic-depressive illness. Soc. Psychiatry Psychiatr. Epidemiol., 30, 213-219.
87. Yatham, L.N., Calabrese, J.R., and Kusumakar, V. (2003) Bipolar depression: criteria for treatment selection, definition of refractoriness, and treatment options. Bipolar Disord., 5, 85-97.